1-6 of 6
Susan L. Holbeck
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity

Susan L. Holbeck, Richard Camalier, James A. Crowell, Jeevan Prasaad Govindharajulu, Melinda Hollingshead, Lawrence W. Anderson, Eric Polley, Larry Rubinstein, Apurva Srivastava, Deborah Wilsker, Jerry M. Collins, James H. Doroshow
Journal: Cancer Research
Cancer Res (2017) 77 (13): 3564–3576.
https://doi.org/10.1158/0008-5472.CAN-17-0489
Published: 01 July 2017
View articletitled, The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity
Open the PDF for The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity in another window
Includes: Supplementary data
Journal Articles

The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology

Ogan D. Abaan, Eric C. Polley, Sean R. Davis, Yuelin J. Zhu, Sven Bilke, Robert L. Walker, Marbin Pineda, Yevgeniy Gindin, Yuan Jiang, William C. Reinhold, Susan L. Holbeck, Richard M. Simon, James H. Doroshow, Yves Pommier, Paul S. Meltzer
Journal: Cancer Research
Cancer Res (2013) 73 (14): 4372–4382.
https://doi.org/10.1158/0008-5472.CAN-12-3342
Published: 15 July 2013
View articletitled, The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology
Open the PDF for The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology in another window
Includes: Supplementary data
Journal Articles

Abstract 1879: The exomes of the NCI60 and their implications for cancer pharmacogenomics

Ogan D. Abaan, Sean R. Davis, Sven Bilke, Eric C. Polley, Robert L. Walker, Marbin Pineda, Yuelin J. Zhu, William Reinhold, Susan L. Holbeck, Richard M. Simon, James H. Doroshow, Yves Pommier, Paul S. Meltzer
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1879.
https://doi.org/10.1158/1538-7445.AM2012-1879
Published: 15 April 2012
View articletitled, Abstract 1879: The exomes of the NCI60 and their implications for cancer pharmacogenomics
Journal Articles

Abstract 2547: NCI-60 combination screening matrix of approved anticancer drugs

Susan L. Holbeck, Jerry M. Collins, James H. Doroshow
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2547.
https://doi.org/10.1158/1538-7445.AM2011-2547
Published: 15 April 2011
View articletitled, Abstract 2547: NCI-60 combination screening matrix of approved anticancer drugs
Journal Articles

Ligand-Directed Surface Profiling of Human Cancer Cells with Combinatorial Peptide Libraries

Mikhail G. Kolonin, Laura Bover, Jessica Sun, Amado J. Zurita, Kim-Anh Do, Johanna Lahdenranta, Marina Cardó-Vila, Ricardo J. Giordano, Diana E. Jaalouk, Michael G. Ozawa, Catherine A. Moya, Glauco R. Souza, Fernanda I. Staquicini, Akihiko Kunyiasu, Dominic A. Scudiero, Susan L. Holbeck, Edward A. Sausville, Wadih Arap, Renata Pasqualini
Journal: Cancer Research
Cancer Res (2006) 66 (1): 34–40.
https://doi.org/10.1158/0008-5472.CAN-05-2748
Published: 05 January 2006
View articletitled, Ligand-Directed Surface Profiling of Human Cancer Cells with Combinatorial Peptide Libraries
Open the PDF for Ligand-Directed Surface Profiling of Human Cancer Cells with Combinatorial Peptide Libraries in another window
Includes: Supplementary data
Journal Articles

COMPARE analysis of the NCI-60 cancer cell lines reveals a pharmacological interplay between farnesyltransferase and tubulin deacetylase.

Jun Zhou, Adam I. Marcus, Susan L. Holbeck, Paraskevi Giannakakou
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 7.
Published: 01 May 2005
View articletitled, COMPARE analysis of the NCI-60 cancer cell lines reveals a pharmacological interplay between farnesyltransferase and tubulin deacetylase.